Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II Class B and Series III Class B ...

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (“Retractable”) (NYSE American: RVP) announced today that its Board of Directors has declared dividends to holders of its Series II ...

Abstract: Needle-Free Injection Systems (NFIS) are rapidly emerging as transformative alternatives to conventional needle-based and auto-injector drug delivery devices. By eliminating hypodermic ...

The last time I spoke about Sanofi (SNY), it was in a Seeking Alpha article entitled "Sanofi Gets In-House Developed Cancer Drug Sarclisa To The Finish Line With FDA Approval." With respect to this ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. We’re sure you’ve heard, but if you haven’t: ...

This question has often run through my head. Maybe it’s the question everyone living with chronic illness asks themselves at certain times. Which is to say, “What is a good life? What is a life worth ...

Zoan Fruits are one of the three types of Devil Fruits that exist. This type of fruit allows the user to transform into a full animal species and a hybrid form of the animal and its original form at ...

The European Commission has approved Sarclisa (isatuximab) subcutaneous (SC) in combination with standard-of-care regimens for the treatment of patients with multiple myeloma (MM) across all existing ...

Ventricular tachycardia (VT) is an abnormal rapid heart rhythm that most commonly occurs in the setting of ventricular scar. In patients with ischaemic cardiomyopathy and VT, the most common mechanism ...